Moongipa Capital Finance Ltd. has fulfilled its regulatory obligations by submitting the mandatory compliance certificate under SEBI (Depositories and Participants) Regulations 2018 for the quarter ended March 31, 2026. The submission was made to BSE Limited on April 03, 2026, ensuring adherence to prescribed timelines.

Regulatory Compliance Details

The certificate was issued under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations 2018, which governs the dematerialization process of securities. This quarterly submission is a mandatory requirement for listed companies to demonstrate proper handling of physical share certificates.

Certificate Confirmation

Skyline Financial Services Private Limited, serving as the company's Registrar and Share Transfer Agent, provided the confirmation certificate dated April 01, 2026. The RTA certified compliance with key regulatory requirements for the dematerialization process.

The certificate confirms two critical aspects of regulatory compliance:

• Securities comprised in the certificates have been listed on the stock exchange where earlier issued securities are listed
• Physical certificates have been properly mutilated and cancelled after due verification, with the depository name substituted in records as the registered owner within the prescribed 15-day timeline

Corporate Information

The submission was signed by Sandeep Singh, Company Secretary and Compliance Officer of Moongipa Capital Finance Limited. The company operates under CIN: L65993DL1987PLC028669 and maintains its registered office at 18/14, W.E.A. Pusa Lane, Karol Bagh, New Delhi-110005.

Regulatory Significance

This quarterly compliance certificate represents the company's commitment to maintaining transparency in its share transfer and dematerialization processes. The timely submission ensures continued compliance with SEBI regulations governing depositories and participants, supporting investor confidence in the company's operational procedures.

Moongipa Capital Finance Limited announced its unaudited standalone financial results for the quarter and nine months ended December 31, 2025. The Board of Directors approved these results during their meeting held on January 15, 2026, which commenced at 12:30 PM and concluded at 2:15 PM.

Financial Performance Overview

The company reported mixed performance for Q3FY26 compared to the previous year and quarter. While total income showed growth year-over-year, profitability declined from the previous quarter.

Revenue Composition

The company's revenue from operations totaled ₹293.39 lakhs in Q3FY26, compared to ₹215.94 lakhs in Q3FY25. Key revenue components included:

Notably, the company reported no net gain on fair value changes in Q3FY26, compared to ₹72.66 lakhs in Q3FY25.

Nine-Month Performance

For the nine months ended December 31, 2025, the company demonstrated strong overall performance:

Key Financial Metrics

The company's financial health indicators as of December 31, 2025:

Rights Issue and Deviation Statement

The company completed a rights issue on January 2, 2025, raising ₹1,527.40 lakhs. According to the deviation statement, all funds raised through the rights issue have been fully utilized in the quarter ended June 30, 2025, as per the Letter of Offer dated November 27, 2024, with no deviation from the stated objectives.

Pursuant to Regulation 32 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the company submitted a nil deviation statement to BSE Limited on January 15, 2026. The statement confirms no deviation or variation in the use of proceeds from the objects stated in the Letter of Offer.

Expense Analysis

Total expenses for Q3FY26 amounted to ₹270.98 lakhs, up from ₹180.05 lakhs in Q3FY25. Major expense categories included:

Regulatory Compliance

The financial results have been prepared in accordance with Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The statutory auditors, M/s Sunil K. Gupta & Associates, Chartered Accountants (Firm Registration No. 002154N), have conducted a limited review of the results and found no material misstatements requiring disclosure. The results were reviewed by the Audit Committee and approved by the Board of Directors.